
Board Members
President/CEO Kunio Iwatani |
| Graduate of Faculty of Pharmacy, Osaka University |
| Vice President of Takeda France S.A. |
| Executive Vice President of TAP Pharmaceuticals, Inc. |
| Director of International Product Management Dept. of Takeda Pharmaceutical Co., Ltd. |
| President/CEO of Hokuriku Seiyaku Co.,Ltd |
| Member of the Board, Abbott Japan Co., Ltd. |
| President/CEO of Kringle Pharma, Inc.(present position) |
| Outside Board Member, AnGes MG, Inc.(present position) |
|
Exective Vice President Director, BD Kiichi Adachi, Ph.D. |
| Graduate of Doctoral Course of Graduate School of Agriculture and Life Science, Tokyo University |
| Postdoctoral Research Associate, Purdue University, IN, U.S.A |
| Research Scientist, Paradigm Genetics, Inc., NC, USA |
| Chief Scientist at Biotechnology Center, Mitsui Global Strategic Studies Institute | | R&D Department Director, Kringle Pharma, Inc. |
| Member of the Board, Kringle Pharma, Inc.(present position) |
| Exective Vice Pesident of Kringle Pharma, Inc.(present position) |
| Business Development Director, Kringle Pharma, Inc.(present position) |
|
Director, R&D Keigo Hanada, D.V.M., Ph.D. |
| Graduate of Graduate School of Agriculture, Veterinary Medicine, Kagoshima University |
| Government of Kagoshima Prefecture |
| Graduate of Graduate School of Medicine, Kyoto University (Ph.D.) |
| Chief Scientist, Kaken Pharmaceutical Co., Ltd. |
| Senior Scientist, Tanabe Seiyaku Co., Ltd. |
| R&D Department Director, Kringle Pharma, Inc.(present position) |
| Invited Assistant Professor, Kringle Pharma Joint Research Division for Regenerative Drug Discovery, the Center for Advanced Science and Innovation
at Osaka University |
| Member of the Board, Kringle Pharma, Inc.(present position) |
|
CSO Kunio Matsumoto, Ph.D. |
| Graduate of Graduate School of Science, Osaka University Doctor of Science (Ph.D.) | | Assistant Professor, Department of Dermatology, Osaka University Medical School |
| Assistant Professor, Department of Biology, Faculty of Science, Kyushu University |
| Associate Professor, Biomedical Research Center, Osaka University |
| Associate Professor, Osaka University Graduate School of Medicine |
| Member of the Board, Kringle Pharma, Inc.(present position) |
| Professor, Division of Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University (present position) |
|
Adviser
Toshikazu Nakamura Ph.D. (Professor) |
| Graduate of Graduate School of Science, Osaka University, Doctor of Science (Ph.D.) |
| Studied at University of California, San Diego (UCSD) |
| Associate Professor at Enzyme Research Institution, Faculty of Medicine, University of Tokushima |
| Professor, Department of Biology, Faculty of Sciences, Kyushu University. |
Professor, Graduate School of Medicine, Osaka University (present position) |
|
Tadao Yamamoto (Legal Counsel) |
|
Joerg Michel
M.D.(Surgical Specialist), D.M.(Doctor of Medicine) |
|
Toshio Kurumagawa (Financial Adviser) |
| Graduate of Osaka University |
| Nippon Life Insurance Company |
| Director of Investment Dept., Nippon Venture Capital Co., Ltd. |
Member of the Board, NISSAY CAPITAL Co., Ltd. (present position) |
|
| Masayoshi Matsumura |
| Graduate of Kyoto Pharmaceutical University |
| President/CEO, Ohta Pharmaceutical Co., Ltd. |
| President/CEO, Teikoku Medix Co., Ltd. |
| Vice President, Teikoku Seiyaku Co., Ltd. |
| Member of the Board, Kringle Pharma, Inc. |
| Chairman/CEO, Medrx Inc. (present position) |
|
|